Greenstone Biosciences is a computational biology startup company located at Stanford Research Park in Palo Alto, California. The company’s mission is to transform drug discovery and accelerate the development of effective therapies for patients.

Greenstone Biosciences integrates high-performance drug discovery, artificial intelligence, and human induced pluripotent cells (hiPSCs) technology to build a drug discovery engine. They are integrating high-performance drug discovery, AI/Machine Learning computing to achieve this new platform.